To understand more precisely which nucleotides were mediating RT-resistance and DNA repair in GBM, we used teriflunomide42,43, an FDA-approved inhibitor of dihydroorotate dehydrogenase (DHODH), a rate limiting enzyme in de novo pyrimidine synthesis (Supplementary Fig. 5A). Here, DHODH is linked to glioblastoma.